StockData
Aethlon Medical Inc logo

Aethlon Medical Inc (AEMD) stock

AEMDNasdaqPharmaceutical PreparationsFiscal year ends March 31
Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/30
$5.11+0.03 (+0.59%)

Close on Nov 18, 2026Market cap $3.63MP/E –Yield –

Aethlon Medical price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Aethlon Medical's price to sales ratio was 73.4× on Jul 31, 2023, against 123.4× a year earlier. Over the last 5 years it ranged from 58.4× to 494.6×, with a median of 228.8×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2023Jul 31, 202373.4×−167.2
2022Oct 31, 2022240.6×+85.5
2021Dec 31, 2021155.1×−85.6
2020Dec 31, 2020240.7×+182.3
2019Dec 31, 201958.4×−436.2
2018Dec 31, 2018494.6×+382.2
2017Oct 31, 2017112.4×−324.0
2015Jul 31, 2015436.3×+166.3
2014Dec 31, 2014270.1×+157.8
2013Dec 31, 2013112.3×+85.1
2012Dec 31, 201227.2×–

More Aethlon Medical figures

See a number that looks wrong?